Table 2 |
||
|
Patients and tumor characteristics in triple-negative breast cancer cohort |
||
|
Parameters |
Number |
Percentage |
|
|
||
|
Age (years) |
||
|
≤50 |
51 |
37.8 |
|
>50 |
84 |
62.2 |
|
Tumor size (mm) |
||
|
≤20 |
44 |
32.6 |
|
>20 |
91 |
67.4 |
|
Lymph node metastases |
||
|
0 |
82 |
60.7 |
|
1-3 |
28 |
20.7 |
|
3< |
24 |
17.8 |
|
Histological grade |
||
|
I |
5 |
3.7 |
|
II |
29 |
21.5 |
|
III |
101 |
74.8 |
|
Maspin |
||
|
Positive |
116 |
85.9 |
|
Negative |
19 |
14.1 |
|
EGFR |
||
|
Positive |
66 |
48.9 |
|
Negative |
69 |
51.1 |
|
CK5/6 |
||
|
Positive |
80 |
59.3 |
|
Negative |
55 |
40.7 |
|
CK14 |
||
|
Positive |
46 |
34.1 |
|
Negative |
89 |
65.9 |
|
CD10 |
||
|
Positive |
24 |
17.8 |
|
Negative |
111 |
82.2 |
|
p63 |
||
|
Positive |
17 |
12.6 |
|
Negative |
118 |
87.4 |
|
|
||
|
Umekita et al. Diagnostic Pathology 2011 6:36 doi:10.1186/1746-1596-6-36 |
||